Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study.

Details

Language :

English

ISSN :

20959907

Volume :

8

Issue :

1

Database :

Complementary Index

Journal :

Signal Transduction & Targeted Therapy

Publication Type :

Academic Journal

Accession number :

162506868

Full Text :

https://doi.org/10.1038/s41392-023-01317-7